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Abstract
Background: To characterise the acute physiological and inflammatory changes induced by low-dose RSV
infection in mice.
Methods: BALB/c mice were infected as adults (8 wk) or weanlings (3 wk) with 1 × 105 pfu of RSV A2 or vehicle
(intranasal, 30 µl). Inflammation, cytokines and inflammatory markers in bronchoalveolar lavage fluid (BALF) and
airway and tissue responses to inhaled methacholine (MCh; 0.001 – 30 mg/ml) were measured 5, 7, 10 and 21
days post infection. Responsiveness to iv MCh (6 – 96 µg/min/kg) in vivo and to electrical field stimulation (EFS)
and MCh in vitro were measured at 7 d. Epithelial permeability was measured by Evans Blue dye leakage into BALF
at 7 d. Respiratory mechanics were measured using low frequency forced oscillation in tracheostomised and
ventilated (450 bpm, flexiVent) mice. Low frequency impedance spectra were calculated (0.5 – 20 Hz) and a
model, consisting of an airway compartment [airway resistance (Raw) and inertance (Iaw)] and a constant-phase
tissue compartment [coefficients of tissue damping (G) and elastance (H)] was fitted to the data.
Results: Inflammation in adult mouse BALF peaked at 7 d (RSV 15.6 (4.7 SE) vs. control 3.7 (0.7) × 104 cells/ml;
p < 0.001), resolving by 21 d, with no increase in weanlings at any timepoint. RSV-infected mice were
hyperresponsive to aerosolised MCh at 5 and 7 d (PC200 Raw adults: RSV 0.02 (0.005) vs. control 1.1 (0.41) mg/
ml; p = 0.003) (PC200 Raw weanlings: RSV 0.19 (0.12) vs. control 10.2 (6.0) mg/ml MCh; p = 0.001). Increased
responsiveness to aerosolised MCh was matched by elevated levels of cysLT at 5 d and elevated VEGF and PGE2
at 7 d in BALF from both adult and weanling mice. Responsiveness was not increased in response to iv MCh in
vivo or EFS or MCh challenge in vitro. Increased epithelial permeability was not detected at 7 d.
Conclusion: Infection with 1 × 105 pfu RSV induced extreme hyperresponsiveness to aerosolised MCh during
the acute phase of infection in adult and weanling mice. The route-specificity of hyperresponsiveness suggests that
epithelial mechanisms were important in determining the physiological effects. Inflammatory changes were
dissociated from physiological changes, particularly in weanling mice.
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Respiratory syncytial virus (RSV) infection is one of the
most common diseases of childhood. It is estimated that
RSV infects up to two-thirds of infants worldwide by one
year of age, with almost all children infected at least once
by the age of 2 [1-3]. Around 75% of children have IgG
antibodies to RSV by 18 months of age [4]. Most RSV dis-
ease manifests as mild upper respiratory tract infection,
however a small proportion of children go on to develop
severe lower respiratory tract disease including bronchi-
olitis and pneumonia requiring hospitalisation. Primary
infection occurs at an average age of 12 months, though
the median age of infants requiring hospital admission is
2 to 3 months [5] and the highest morbidity of RSV dis-
ease is seen below the age of 6 months [6-9]. Severe cases
place a large burden on the health-care system; acute
bronchiolitis and bronchitis are the sixth most common
causes of hospital admissions in Australian children [10].
Acute RSV lower respiratory tract infection is associated
with wheezing, airways hyperresponsiveness, airflow
obstruction and alterations in gas exchange (reviewed in
[11]).
Mice are commonly used as experimental models of
human RSV infection [12]. While inoculation with high
titres of RSV is necessary for replication to occur within
the lungs due to the semi-permissive nature of RSV infec-
tion in the mouse host, clinical and pathological changes
vary markedly with dose. Infection with low titres (103 –
105 plaque forming units (pfu) induces peribronchial and
perivascular inflammation [13-15] but fails to induce
clinical signs of illness [15]. In contrast, infection with
high titres of RSV (~107 pfu) induces clinical signs of ill-
ness and weight loss [15-19] in conjunction with severe
histopathological changes and pneumonia [17,20,21]
that can persist for long periods of time (154 days [20,21].
Current physiological data describing the effects of RSV
infection are limited, particularly due to the use of the
parameter 'enhanced pause' (Penh) derived from unre-
strained plethysmography [20-23]. Penh is widely
regarded as being primarily related to ventilatory timing
and contains little information on the physiological state
of the airways [24]. Few studies have examined the physi-
ological response to bronchoconstrictor challenge in intu-
bated mice infected with RSV [15,18,25] and the
physiological alterations that occur in response to RSV are
yet to be clearly defined in terms of the site of responsive-
ness and baseline changes in airway and parenchymal
mechanics.
The aim of the present study was to assess the physiologi-
cal changes occurring in the airways and parenchyma of
mice infected with RSV, and to relate these alterations to
the inflammatory profile induced by infection. Due to the
proven success of low dose RSV models in producing
inflammatory and histopathological changes, we have
used a low dose (105 pfu) model of infection in order to
avoid the excessive pathology and structural damage that
may confound our physiological measurements. We have
also sought to determine whether the physiological




BALB/c mice were selected for all studies due to their avail-
ability, level of responsiveness to bronchoconstrictor
challenge and permissiveness to RSV infection [12]. Mice
were obtained from the Animal Resource Centre (Mur-
doch, Western Australia) and maintained under specific
pathogen free conditions at the Telethon Institute for
Child Health Research (TICHR), with food and water
available ad libitum. Experimental procedures were
approved by the TICHR Animal Ethics Committee and
conformed to the guidelines of the National Health and
Medical Research Council of Australia.
Infection of mice with RSV
Mice were inoculated with 1 × 105 pfu of sucrose gradient
purified human RSV A2 or the equivalent concentration
of sucrose buffer as weanlings (21 d; weaning) or adults (8
wk). RSV was delivered to each mouse in a 30 µl inoculum
under light anaesthesia (Methoxyfluorane, Medical
Developments Pty Ltd, VIC, Australia) by pipetting drops
of inoculum onto one nostril until the entire volume had
been aspirated. Mice were laid on their side with their
mouth held closed during inoculation to prevent inges-
tion.
Mice were housed in individually ventilated cages (IVC
Sealsafe, Tecniplast, Italy) during the acute phase of infec-
tion. Low velocity HEPA filtered air was delivered to cages
maintained under negative pressure.
Clinical signs of illness
Mice were weighed and scored for clinical signs of illness
daily until 7 d post inoculation and then every 2nd or 3rd
day until 21 d. Mice were scored on the basis of appear-
ance and demeanour, according to the scale described by
Graham and colleagues [26]. A score of 0 indicated no vis-
ible signs of ill health; 1 – barely ruffled fur; 2 – ruffled but
active; 3 – ruffled and inactive; 4 – ruffled, inactive,
hunched and gaunt; 5 – dead. Mice were killed if they fell
below 70% of their original bodyweight and/or had a
clinical score of ≥ 3.
Lung viral titre
Viral titres were assessed in lung homogenates at 5 d post
inoculation by TCID50 assay on HEp-2 cells as described
in [27].Page 2 of 18
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Anaesthesia
Mice were anesthetized by intraperitoneal injection of 0.1
ml/10 g bodyweight of a mixture of ketamine (40 mg/ml,
Troy Laboratories, NSW, Australia) and xylazine (2 mg/
ml, Troy Laboratories, NSW, Australia). No muscle relax-
ants were used. Two thirds of the dose was used to induce
surgical anaesthesia and the remainder was given once the
mouse was attached to the ventilator. Additional doses
were given as required. Once surgical anaesthesia was
established a tracheotomy was performed by insertion of
a straight polyethylene cannula (internal diameter =
0.086 cm, length = 1.0 cm) into the distal trachea.
Oscillatory lung mechanics
Mice were ventilated with a flexiVent® small animal venti-
lator (SCIREQ, Montreal, PQ, Canada) at 450 breaths per
minute and a tidal volume of 8 ml/kg. A positive end-
expiratory pressure was set at 2 hPa. The ventilation rate
was set above the normal breathing rate to suppress spon-
taneous breathing during measurements. Mice were
allowed to stabilize on the ventilator for 5 minutes before
measurements commenced. Respiratory system imped-
ance (Zrs) was measured using a modification of the low-
frequency forced oscillation technique (FOT [28] as previ-
ously described [29]. Respiratory input impedance (Zrs)
was measured between 0.5 and 20 Hz by applying a com-
posite signal containing 19 mutually prime sinusoidal
waves during pauses in regular ventilation. The peak-to-
peak amplitude of the oscillatory signal was 50% of tidal
volume. The flexiVent ventilator was used both for regular
ventilation and for delivery of the oscillatory signal with-
out the need to disturb the mice. Measurements were
excluded if coherence was < 95%.
Constant phase parameter estimation
The constant-phase model described by Hantos et al. [30]
was used to partition Zrs into components representing
the mechanical properties of the airways and parenchyma.
The constant-phase model [30] was fitted as follows: Zrs =
R + jωI + (G-jH)/ωα, where R is the Newtonian resistance
(primarily located in the airways but containing a contri-
bution from the chest wall), I is the inertance, G is the co-
efficient of tissue damping, H is the co-efficient of tissue
elastance, ω is the angular frequency and α represents the
reciprocal frequency-dependent behaviour of G & H.
Strictly speaking, the parameters Raw and Iaw, respec-
tively, include the Newtonian components of tissue resist-
ance and tissue inertance. However, measurements in
intact and open-chest rats [31,32] demonstrate that the
contributions of the tissues to Raw and Iaw can be
neglected. We have also previously shown that the chest
wall makes little contribution to Newtonian resistance in
mice and thus R ≈ Raw [33].
Total cells in BALF from adult and weanling mice inoculated with RSV or diluent controlFigure 1
Total cells in BALF from adult and weanling mice inoculated with RSV or diluent control. Adult mice had significantly elevated 
total cell numbers in BALF at 7 and 10 d post inoculation that returned to control levels by 21 d. Weanling mice did not have 
increased cell numbers in BALF at any timepoint.Page 3 of 18
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i) Aerosol MCh challenge
Following measurement of baseline lung function, mice
were challenged with a saline control aerosol followed by
increasing concentrations of β-methacholine chloride
(MCh; Sigma-Aldrich, MO, USA; 0.001 – 30 mg/ml). Aer-
osols were generated with an ultrasonic nebuliser (DeVil-
biss UltraNeb 2000, Somerset, PA, USA) and delivered to
the inspiratory line of the flexiVent using a bias flow of
medical air. Each aerosol was delivered for 2 minutes dur-
ing which time regular ventilation was maintained. Five
measurements were made at one-minute intervals follow-
ing each aerosol. The peak response at each MCh dose was
compared to the mean response to saline. Responsiveness
is expressed as the provocative concentration of MCh
required to induce a doubling of Raw or a 50% increase in
G and H (PC200 or PC150). Responsiveness to aerosolized
MCh was assessed at 5, 7, 10 and 21 d post RSV infection
and 5 and 21 d post control inoculation in 6–10 mice per
group. These days were chosen to coincide with peak viral
titres, peak inflammatory response, viral clearance and
resolution of lung disease, respectively [12,13].
ii) Intravenous MCh challenge
Intravenous MCh challenge was performed at 7 d post
infection (n = 6–8 per group), the time of peak respon-
siveness to aerosolised MCh in both adult and weanling
mice. Increasing doses of MCh were administered by con-
stant infusion (3 – 96 µg/min/kg; Stoelting syringe pump,
Wood Dale, IL, USA) via a polyethylene cannula (length =
27 cm; outer diameter = 0.061 cm) inserted into the jugu-
lar vein. MCh-induced constriction was reversed by intra-
peritoneal injection of atropine sulfate (120 µg or ~6 mg/
kg; Pharmacia & Upjohn, WA, Australia; adapted from
[34] during continued infusion of MCh at the highest rate.
Responsiveness of tracheal segments in vitro
Tracheal smooth muscle (TSM) responsiveness was
assessed in vitro by electrical field stimulation (EFS) and
MCh challenge at 7 d post infection (n = 6–7 RSV, n = 5–
8 control from each age group). Mice were anaesthetised
as per preparation for in vivo measurement of oscillatory
mechanics. Tracheal segments of approximately 0.5 cm in
length were removed and cleaned of loose connective tis-
sue and placed in 50 ml organ baths (Radnotti Glass Tech-
nology, CA, USA). The TSM segment was attached to a
fixed lower support and a tri-shape tissue support con-
nected to a force-displacement transducer (Model FT03E;
Grass Instrument Co., MA, USA). The tissue was sus-
pended between horizontal platinum wire electrodes (AD
Instruments, NSW, Australia).
The tissues were bathed in modified Krebs-Henseleit solu-
tion containing (in mM): 118NaCl, 25NaHCO3,
2.8CaCl2.2H2O, 1.17MgSO4, 4.7 KCl, 1.2KH2PO4 and
11.1 glucose. The baths were aerated with a 95% O2-5%
CO2 gas mixture. The temperature of the baths was main-
tained at 37°C. Each TSM segment was equilibrated in the
bath for 30 min at an optimal resting tension of 0.70 g.
During this equilibration time, the tissue was challenged
once with 10-4 M MCh. Tissues that did not develop a con-
tractile response were excluded from further studies. Tis-
Differential cell counts in adult and weanling mice after RSV and control inoculationFigu  2
Differential cell counts in adult and weanling mice after RSV and control inoculation. Macrophages were the predominant cell 
type in both age groups. Total macrophage and neutrophil numbers were increased in adult mice at 7 and 10 d post infection; 
however this did not reach statistical significance.Page 4 of 18
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periodically and allowed to relax to their initial tension
after reaching maximal contraction.
Recordings of resting tensions and TSM contractile
responses were made using a PowerLab 8/s Recorder and
Chart 5.1.1 software (AD Instruments, NSW, Australia).
EFS (30 V, 3 ms square wave pulses at 0.5, 1, 2, 5, 10, 20,
30, 40 Hz) were delivered via platinum electrodes by a
Grass S44 stimulator connected to a stimulus isolation
unit (Grass Instruments, MA, USA). The stimulus was
applied until the tissue reached a maximum contraction
(~10 s). The tissue was washed after every second stimula-
tion to ensure that the relative concentrations of the ions
in the Krebs-Henseleit solution were maintained. EFS
responsiveness is expressed as the frequency required to
induce 50% of the maximal contractile response (EC50).
To assess cholinergic sensitivity of the tissues, cumulative
dose-response curves to MCh were performed in half-log
increments employing concentrations ranging from 10-8
to 10-4 M. Results from MCh challenge are expressed as a
percentage of the maximal contractile response as well as
the EC50. Tissues were washed and rested repeatedly
between EFS and MCh challenge.
Bronchoalveolar lavage and lung fixation
Lungs were lavaged at the completion of lung function
measurements and just prior to death of the animal by
washing 1 ml of ice-cold lavage fluid (0.9% saline con-
taining 0.35% lidocaine (Sigma, St Louis, MO, USA) and
0.2 % BSA (CSL Ltd, Parkville, VIC, Australia) in and out
of the lungs three times. Bronchoalveolar lavage fluid
(BALF) was processed for total and differential cell counts.
Cytospins for differential counts were stained with Leish-
mans stain (BDH Laboratory Supplies, Poole, England).
Lavage supernatants were stored at -80°C. Total and dif-
ferential cell counts were performed on lavage samples
from 6–10 mice per group.
Lungs were inflation fixed in situ in 10% phosphate-buff-
ered formalin (Confix, Autralian Biostain Pty Ltd, VIC,
Australia) at a distending pressure of 10 hPa for 1–2 hours
before ligation and removal from the chest cavity. Lungs
were immersion fixed in formalin overnight before being
transferred to 70% ethanol and stored at 4°C until
processing. Paraffin embedded lungs were sectioned at 5
µm thickness and stained with haematoxylin and eosin.
Measurement of cytokines and mediators in BALF
In order to characterise the primary inflammatory and
cytokine response to RSV infection, we chose the appro-
priate kit to measure innate immune responses. This
included tumour necrosis factor alpha (TNFα), interferon
gamma (IFNγ), macrophage chemotactic protein 1 (MCP-
1) and interleukins (IL) 6, 10 and 12 (p70 protein) and
these were measured in BALF supernatants by cytometric
bead assay (BD Biosciences, CA, USA) according to the
manufacturer's instructions. Prostaglandin E2 (PGE2), IL-
13, vascular endothelial growth factor (VEGF) and cystei-
nyl leukotrienes (cysLT) were measured as potential medi-
ators of airway hyperresponsiveness using enzyme
immunoassay kits (PGE2, cysLT: Cayman Chemicals, MI,
USA; IL-13, VEGF: Quantikine, R&D Systems, MN, USA)
according the manufacturer's instructions. Cytometric
bead assay and cysLT ELISA were performed at 5, 7 and 21
d post RSV inoculation and at 5 and 21 d post diluent con-
trol inoculation. IL-13, VEGF and PGE2 were measured at
5 and 7 d post RSV inoculation and at 5 d post control
inoculation.
Measurement of epithelial permeability using Evans Blue 
dye
Evans Blue dye (EBD) is a useful indicator of microvascu-
lar permeability [35]. EBD (Sigma-Aldrich, MO, USA) was
administered intravenously to mice via the jugular vein
following iv MCh challenge as described by Tulic et al.
[36]. A slow bolus of 50 mg/kg EBD was delivered in a vol-
ume of 0.1 ml/10 g bodyweight through the existing iv
cannula. Mice were ventilated for a further 30 minutes
before post-EBD BAL was performed. The amount of EBD
in BALF was quantified by reading the absorbance of the
samples at 620 nm using a microplate reader (Bio-Tek
Instruments, VT, USA). The amount of dye was calculated
by interpolation on a standard curve in the range of 1 – 10
µg/ml [37]. Measurement of epithelial permeability was
performed at 7 d post infection in adult mice only (n = 8
control, 7 RSV).
Statistical analysis
RSV groups were compared vs. combined control groups
where no differences were observed between controls at 5
and 21 d. Differences in bodyweight, viral titre and EBD
concentrations between groups were compared using
unpaired t-test. Differences in total and differential cell
counts, baseline physiology, cytokine and mediator assays
were tested by 1-way analysis of variance (ANOVA) fol-
lowed by Dunnett's post-hoc test for normally distributed
data, and by Kruskal-Wallis ANOVA on ranks followed by
Dunn's test for non normal data. Differences in MCh
responsiveness in vivo between RSV infected and control
animals were tested by 1-way ANOVA on PC200/150 data
for aerosol MCh challenge, and by 2-way repeated meas-
ures ANOVA for iv MCh challenge. In vitro responsiveness
of TSM segments was tested using 1-way ANOVA on EC50
data. Data are expressed as mean (SE). Graphs were pre-
pared using SigmaPlot software (SigmaPlot 2000, SPSS
Science, IL, USA). Statistical analysis was performed using
SigmaStat software (version 2.03, SPSS Science, IL, USA).
Significance was accepted at p < 0.05.Page 5 of 18
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Clinical illness
Mice infected with RSV did not exhibit clinical signs of ill-
ness during the acute phase of infection. Adult mice
infected with RSV did not decrease in bodyweight com-
pared to controls (p = 0.41). RSV infected weanling mice
gained weight at the same rate as control animals, both
groups reaching 125–130% of their original bodyweight
by 5 d post inoculation (p = 0.66; Figure 1). No mice were
culled for excessive weight loss or clinical score ≥ 3.
Viral titre
Adult and weanling mice had similar levels of RSV repli-
cation in lung homogenates at 5 d post inoculation (4.96
and 4.92 × 104 TCID50/g, respectively).
Inflammation
Adult mice
Adult mice had significantly increased inflammatory cell
numbers in BALF at 7 and 10 d post inoculation (p <
0.001). Cell numbers had returned to control levels by 21
d (Figure 1). Despite increased cell numbers, differential
cell counts did not reveal a difference in the type of infil-
trating cells at any timepoint and were dominated by mac-
rophages (Figure 2). Mild peribronchiolar and
perivascular inflammation was evident in histological sec-
tions at 5 d post RSV infection (Figure 3B), and had
increased in severity at 7 d post infection (Figure 3C).
Inflammatory cells were also visible in the lung paren-
chyma at 7 d (Figure 3C). Control mice did not show any
evidence of inflammation at 5 d post inoculation (Figure
3A).
Weanling mice
Inflammatory cell numbers in BALF did not change in
weanling mice inoculated with RSV or diluent control (p
= 0.191; Figure 1). Similarly, there was no difference in
cell profile in BALF (Figure 2). Histological sections from
weanling mice inoculated with diluent control and at 5 d
post RSV infection showed little or no inflammatory infil-
trate around airways, blood vessels or in the lung paren-
chyma (Figure 3D, E, respectively). Peribronchiolar and
perivascular inflammation were evident to a small extent
at 7 d post infection (Figure 3F), with infiltration of lym-
phocytes seen.
Airway and parenchymal mechanics
Baseline lung function
In keeping with the mild inflammatory changes observed
in histological sections, there was no evidence of airway
obstruction or increased tissue stiffness at baseline in RSV-
infected mice. RSV infection did not alter baseline Raw, G
or H in adult mice (Table 1). Weanling mice had higher
values of Raw, G and H than adult animals, consistent
with age-related alterations in respiratory mechanics [38],
although H decreased to approach adult values by 21 d
(Table 1). Raw and G were not altered in RSV-infected
weanling mice at baseline. H was decreased in weanling
mice at 21 d post infection, but only when compared to 5
d controls (p = 0.003; p < 0.05 vs. 5 d control).
Responsiveness to MCh
i) Aerosol MCh challenge
Adult mice exhibited extreme hyperresponsiveness to aer-
osolised MCh (Figure 4) in both airway and tissue com-
partments at 5 and 7 d post RSV inoculation (Raw, G, H:
p = 0.003, 0.007, <0.001, respectively), requiring an
approximately 100-fold lower concentration of MCh than
control animals to elicit a doubling of the response (Fig-
ure 5). The response to MCh at 10 d was more variable,
with approximately half of the mice studied having
returned to control levels of responsiveness by this time-
point. Responsiveness had returned to control levels in all
animals studied by 21 d.
Table 1: Baseline airway and tissue mechanics in adult and weanling mice. Values: mean (SE).
Age Treatment Weight (g) Raw hPa.s.ml-1 G hPa.ml-1 H hPa.ml-1
Adult Control 5 d 19.3 (0.4) 0.33 (0.02) 5.1 (0.2) 37.3 (1.3)
Control 21 d 17.9 (0.6) 0.33 (0.02) 5.4 (0.5) 36.5 (2.3)
RSV 5 d 17.1 (0.2) 0.38 (0.03) 5.2 (0.2) 40.9 (1.8)
RSV 7 d 18.2 (0.3) 0.35 (0.03) 5.9 (0.3) 44.3 (2.4)
RSV 10 d 16.7 (0.3) 0.39 (0.03) 5.2 (0.3) 41.5 (2.1)
RSV 21 d 18.7 (0.4) 0.43 (0.02) 4.8 (0.3) 40.3 (2.5)
Weanling Control 5 d 13.9 (0.6) 0.51 (0.04) 7.0 (0.4) 61.6 (2.6)
Control 21 d 16.7 (0.6) 0.48 (0.03) 6.5 (0.8) 57.7 (2.9)
RSV 5 d 13.9 (0.5) 0.53 (0.08) 7.6 (0.4) 69.6 (5.7)
RSV 7 d 15.1 (0.3) 0.52 (0.03) 7.8 (0.5) 64.0 (3.1)
RSV 10 d 15.5 (0.5) 0.52 (0.05) 8.5 (0.7) 65.6 (6.7)
RSV 21 d 16.3 (0.5) 0.39 (0.02) 6.3 (0.4) 45.1 (3.5)*
* p < 0.05 vs. d5 control, not significant vs. d21 controlPage 6 of 18
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Representative sections from adult (A-C) and weanling (D-F) mice inoculated with diluent control (A, D) or RSV (B, C, E, F), each showing an airway (*) and blood vessel (bv)Figure 3
Representative sections from adult (A-C) and weanling (D-F) mice inoculated with diluent control (A, D) or RSV (B, C, E, F), 
each showing an airway (*) and blood vessel (bv). Perivascular and peribronchiolar inflammation were evident to a small degree 
at 5 d post RSV (B); and to a much greater extent at 7 d post RSV (C) in adult mice. Some parenchymal inflammation was also 
present at 7 d. Little to no evidence of inflammation existed in weanling mice at 5 d post infection (E); however a small degree 
of perivascular and peribronchiolar inflammation was present at 7 d post infection (F). Based on morphology these cells were 
classified as lymphocytes. Control mice did not show any evidence of inflammation at either age (A, D). Bar = 50 µm.
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Dose-response curves to aerosolised MCh challenge in adult mice showing airway resistance (A, B), tissue damping (C, D) and tissu  elasta c  (E, F)Fig r  4
Dose-response curves to aerosolised MCh challenge in adult mice showing airway resistance (A, B), tissue damping (C, D) and 
tissue elastance (E, F). Hyperresponsiveness was clearly evident in airways and tissues at 5 and 7 d post RSV infection (A, C, E). 
A mixed response was seen at 10 d post infection (B, D, and F).
Respiratory Research 2005, 6:142 http://respiratory-research.com/content/6/1/142Weanling mice had more variable responses to MCh but
were still hyperresponsive to aerosolised MCh at 5 and 7
d (p = 0.001, < 0.001, <0.001 for Raw, G, H respectively)
(Figure 6). A mixed response was again seen at 10 d.
Weanling mice required an approximately 10-fold lower
Concentrations of aerosolised MCh required to induce a doubling of the salin  response in t e airways (A), or a 50% increase in the respons  of th lung parenchyma (B, C) of wean miceFigure 6
Concentrations of aerosolised MCh required to induce a 
doubling of the saline response in the airways (A), or a 50% 
increase in the response of the lung parenchyma (B, C) of 
weanling mice. Significantly lower concentrations of MCh 
were required to induce responses at 7 and 10 d post infec-
tion in Raw (A), 7 d in G (B) and 5 and 7 d in H (C). The 
response at 10 d post infection was more consistent than in 
adult mice, however responsiveness in general was much 
more variable in weanlings.
Concentrations of aerosolised MCh required to induce a doubling of the response to saline in the airways (A), or a 50% incre se in the resp n  of the lung parenchyma (B, C) of adult micFigure 5
Concentrations of aerosolised MCh required to induce a 
doubling of the response to saline in the airways (A), or a 
50% increase in the response of the lung parenchyma (B, C) 
of adult mice. Significantly lower concentrations of MCh 
were required to induce responses at 5 and 7 d post infec-
tion in Raw and H (A, C), and at 7 d in G (B). A mixed 
response was evident at 10 d post infection in both airway 
and tissue compartments.Page 9 of 18
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had returned to control levels by 21 d.
ii) Intravenous MCh challenge
Neither adult nor weanling mice exhibited increased air-
way or tissue responsiveness to iv MCh compared to con-
trols at 7 d post inoculation. Weanling mice infected with
RSV were slightly smaller than controls (control 13.7
(0.35) g; RSV 11.8 (0.35) g, causing a small upward shift
in the curve that was not related to altered responsiveness
(Figure 7). This weight difference was maintained from
the time of inoculation and due to variation in litter size
rather than weight loss from RSV-induced illness.
In vitro responsiveness
TSM segments from adult and weanling mice infected
with RSV did not exhibit increased responsiveness to EFS
post inoculation (adult EC50 (Hz): RSV 2.59 (1.32) vs con-
trol 1.68 (0.56); weanling EC50 (Hz) RSV 2.23 (0.74) vs
control 1.77(0.84). Similarly, there was no change in
responsiveness to MCh at 7 d (Figure 8).
Cytokines and mediators in BALF
Cytometric bead assay
IL-12 p70 was not detectable in BALF from adult mice at
any timepoint, irrespective of treatment (data not shown).
TNFα, IFNγ, MCP-1 and IL-6 were undetectable in control
samples and at 5 and 21 d post RSV inoculation but were
significantly increased at 7 d post RSV (p < 0.001; Figure
9A–C). IL-6 was increased at 7 d but did not reach signif-
icance in post-hoc analysis (p = 0.011; Figure 9D). IL-10
levels were not altered by RSV infection (p = 0.125, data
not shown).
IL-12 p70, TNFα, IFNγ, MCP-1 and IL-6 were all below
detectable levels in BALF from weanling mice at all time-
points (data not shown). Although detectable, IL-10 levels
were not altered by RSV infection (data not shown).
Prostaglandin E2
PGE2 was elevated in BALF from both adult and weanling
mice, peaking at 7 d post infection (p < 0.001) (Figure
10).
Cysteinyl leukotrienes
Increased levels of cysLT were detected in BALF from adult
and weanling mice (p = 0.029, 0.009 respectively), peak-
ing at 5 d post RSV inoculation (Figure 11). Despite a great
deal of variability, the increase was significant in adult
mice at 5 d (p < 0.05), but did not reach significance in
weanling mice.
IL-13
IL-13 was undetectable in all samples (data not shown).
VEGF
VEGF was elevated at 7 d post infection in both adult and
weanling mice (both p < 0.001). Neither age group had
elevated VEGF levels at 5 d post infection (Figure 12).
Airway resistance in response to iv MCh challenge in adult and weanling mice at 7 d post infectionF gure 7
Airway resistance in response to iv MCh challenge in adult and weanling mice at 7 d post infection. RSV infected mice (closed 
symbols) did not demonstrate increased responsiveness to any concentration of iv MCh compared to controls (open symbols) 
at either age. Raw returned to baseline levels following atropine administration. RSV-infected weanling mice had slightly ele-
vated Raw throughout the iv challenge, although this was due to their smaller size rather than altered responsiveness.Page 10 of 18
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Microvascular permeability measured by Evans blue dye
extravasation into BALF was not increased in adult mice at
7 d (p = 0.25; data not shown). Microvascular permeabil-
ity was not measured in weanling mice.
Discussion
Our low dose model of RSV infection was successful in
achieving viral replication and physiological alterations to
airway (Raw) and parenchymal (G, H) function in the
lungs of both adult and weanling mice. The level of
responsiveness was somewhat dissociated from the
observed inflammatory changes, particularly in the
younger mice. As expected with the dose of RSV adminis-
tered [15], mice did not lose weight or show clinical signs
of illness during the acute phase of infection. Weanling
mice infected with RSV gained weight at the same rate as
controls.
Inflammatory changes
Adult mice showed modestly elevated inflammatory cell
numbers in BALF that peaked at 7 d post infection and
returned to control levels by 21 d (Figure 1). Inflamma-
tory cell numbers were not elevated in adult mice at 5 d
post infection, indicative of a delay between viral replica-
tion in the lung and initiation of the cell-mediated
immune response. Weanling mice did not show any
increase in infiltrating inflammatory cell numbers above
control mice at any timepoint, suggesting that this level of
viral replication was insufficient to induce a detectable
cell-mediated immune response. The cell profile was not
altered in either age group, and consisted predominantly
of macrophages at all timepoints (Figure 2). Histological
sections revealed a mild peribronchiolar and perivascular
inflammation 5 d post infection in adult mice, becoming
more extensive at 7 d. Weanling mice at 5 d did not appear
different to controls, however a small degree of inflamma-
tion was seen in weanling mice at 7 d post infection (Fig-
ure 3).
The cytokine profile measured in BALF from adult and
weanling mice mirrored the inflammatory profile, with
adult mice showing increased levels of TNFα, IFNγ, MCP-
1, IL-6 and VEGF at 7 d post infection but not at 5 d (not
measured at 10 d) (Figures 9 and 12). In keeping with
inflammatory cell numbers, weanling mice did not have
elevated TNFα, IFNγ, MCP-1 or IL-6 in BALF at any time-
point, although VEGF was elevated at 7 d post infection
(Figure 12). IL-13 has previously been identified as an
important mediator of AHR in RSV infected DBA/J and
BALB/c mice [25], however it was undetectable in the
present study. In the absence of significant numbers of
infiltrating lymphocytes, the absence of IL-13 in these
samples is unsurprising. These results suggest that the
Responsiveness of isolated TSM segments from adult and weanling mice to MCh challenge at 7 d post infectionFigure 8
Responsiveness of isolated TSM segments from adult and weanling mice to MCh challenge at 7 d post infection. RSV infected 
mice (closed symbols) did not demonstrate altered bronchoconstrictor responses in vitro compared to controls (open sym-
bols) when infected as either adults or weanlings.Page 11 of 18
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RSV infection did not alter baseline airway or parenchy-
mal mechanics in mice infected as adults or weanlings
(Table 1). Age-related differences in respiratory mechanics
were apparent between age groups and in weanling mice
between the 5 and 21 d timepoints, although this pattern
was not altered by RSV infection. These data suggest that
the low levels of inflammation observed in tissue sections
were insufficient to cause airway obstruction (increased
Raw) or stiffening of parenchymal tissues (increased G
and/or H).
Aerosol MCh
Both adult and weanling mice demonstrated extreme air-
way and parenchymal hyperresponsiveness to aerosolised
MCh, although the response in weanlings was more vari-
able. Adult mice required an approximately 100-fold
lower dose of MCh than controls for a doubling response
(Figures 4, 5); weanlings required on average 10-fold less
MCh than control animals (Figure 6). The concentration
of MCh required for response seen in these mice is sub-
stantially lower than has been demonstrated by other
studies (generally requiring ~10 mg/ml) using similar
infective doses of RSV [22,23,39,40]. Control mice
responded at a somewhat lower MCh dose than naïve
BALB/c routinely measured in our laboratory (data not
shown), indicating that the sucrose buffer solution may
have induced some degree of hyperresponsiveness.
Despite the level of responsiveness of the control animals,
RSV infection still induced a clear leftward shift of both
the airway and parenchymal dose-response curves repre-
Cytokine levels in BALF from adult miceFigure 9
Cytokine levels in BALF from adult mice. TNFα (A), IFNγ (B) and MCP-1 (C) concentrations were all increased at 7 d post 
infection and undetectable in controls and at other timepoints. IL-6 was elevated to a small extent at 7 d (D) but did not reach 
significance in post-hoc analysis.Page 12 of 18
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lenge.
AHR to MCh in RSV-infected mice has primarily been
detected using unrestrained plethysmography [22,23,39],
an inherently non-specific means of measuring airway
function [24]. We were not surprised at differences
between our results and those obtained with Penh, given
that FOT contains direct physiological information on air-
way and parenchymal behaviour. Penh data obtained dur-
ing MCh challenge is also likely to be contaminated by
increased nasal resistance due to respiratory secretions
induced by cholinergic stimulation. A potential advantage
of unrestrained plethysmography over FOT may lie in the
ability to test unsedated animals, but we would expect
sedation to reduce responsiveness rather than increase it
[41,42]. More reliable physiological data comes from
Dakhama et al. [40], who demonstrated AHR to MCh in
intubated mice using total lung resistance. The magnitude
of the response detected in the present study coupled with
the similar pattern of responsiveness in the airway and
parenchymal compartments suggests that degree of sensi-
tivity to MCh detected in the present study is not simply a
function of a more sensitive measurement technique rela-
tive to other studies. While partitioning of Zrs into airway
and tissue mechanics allows detection of more subtle
changes than total lung or respiratory system impedance,
it seems unlikely that responses of this magnitude would
not be detected using other measurement systems.
Intravenous MCh and MCh in vitro
In contrast to challenge with aerosolised MCh, respon-
siveness to iv MCh challenge was not altered in mice
infected with RSV as adults or weanlings (Figure 7). Simi-
larly, we did not observe increased responsiveness to MCh
in tracheal segments from adult or weanling mice at 7 d
(Figure 8). The contrasting effects of different routes of
agonist delivery suggest that delivery of MCh directly to
the epithelial surface is crucial in inducing hyperrespon-
siveness. Conflicting data exists in the literature on the
response to iv MCh in RSV-infected mice; similar doses of
iv MCh have been shown to induce hyperresponsiveness
in mice infected with 3 × 105 pfu RSV [25] and 107 pfu RSV
[15], and to be unable to induce hyperresponsiveness in
mice infected with 107 pfu RSV [18].
Responsiveness to EFS in vitro
In the present study, responsiveness of tracheal segments
to EFS in vitro was unaltered in RSV-infected mice. Using
a slightly higher dose of RSV (106 pfu), Dakhama et al.
[40] demonstrated increased responsiveness of murine
tracheal smooth muscle segments to EFS at 6 d post infec-
tion, without any increase in maximal tension. Similarly,
Colasurdo and colleagues have demonstrated increased
responsiveness to EFS but no change in maximal tension
at 4 d post infection in cotton rats [43]. The reason for the
discrepancy in EFS responsiveness between published
studies and the results we report here is not clear. While
the dose used by Dakhama et al. [40] was somewhat
higher, inflammatory cell numbers in BALF were identical
(in adult mice) to our study, suggesting similar severity of
infection. Differences in responsiveness between mice
and cotton rats does not seem surprising given the greater
permissiveness of cotton rats to RSV infection, however
the similar pattern of responses seen in the aforemen-
tioned studies suggests that species differences do not play
PGE2 levels in BALF from adult and weanling miceFigur  10
PGE2 levels in BALF from adult and weanling mice. Significantly elevated levels were detected at 7 d post RSV infection in both 
age groups.Page 13 of 18
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EFS in vitro does, however, argue against any alterations
in neural control of airway smooth muscle (ASM) and the
lack of increased responsiveness to MCh in vitro argues
against alterations in ASM contractile properties following
RSV infection.
Mechanisms of route-specific hyperresponsiveness
The discrepancy in responsiveness between in vivo and in
vitro conditions may reflect differences in the site of
responsiveness within the airway tree. The use of extratho-
racic tracheal segments in vitro may ignore alterations in
airway function occurring further down the airway tree.
This may be particularly relevant when the site of RSV rep-
lication within the mouse lung is considered; the virus
replicates mostly in small airways and alveolar epithelial
cells rather than epithelial cells in large conducting air-
ways. While technically more difficult, assessment of the
responsiveness of bronchi or intrathoracic airways may
yield a greater response in vitro [44]. Airway resistance as
measured in vivo represents a greater proportion of the
airway tree and thus may be more sensitive to changes
occurring in regions of the airway other than the trachea.
Differences in levels of responsiveness between different
modes of agonist delivery in the present study bear strong
resemblance to studies investigating the effects of cationic
proteins on airway function published in the 1990's [45-
47]. After the discovery that treatment with cationic pro-
teins (major basic protein, poly-L-lysine and poly-L-
arginine) increased airway responsiveness to inhaled
MCh in rats [47], further investigation in isolated airways
revealed that hyperresponsiveness was induced only if
MCh was delivered to the luminal surface of the airway in
vitro. Delivery of MCh to the external surface of the airway
wall did not alter responsiveness irrespective of pre-treat-
ment with cationic proteins [45,46]. Thus, hyperrespon-
siveness was only manifested when the challenging
agonist had to cross the airway epithelium to reach the
underlying ASM, and implicates the integrity of the epi-
thelial layer as important in the response to inhaled ago-
nists.
Epithelial mechanisms are the most likely candidates to
explain the results of the present study, in which hyperre-
sponsiveness was only induced by aerosol delivery of
MCh in vivo. We did not examine luminal vs. external
administration of MCh in vitro, but can instead compare
aerosol and iv delivery in vivo. Disruption of epithelial
barrier function or alterations in signalling are potential
candidates to explain the site-specificity of agonist action
of airway responsiveness. VEGF is upregulated in nasal
washings from RSV-infected children [48] and in human
epithelial cells infected with RSV in vitro [48,49]. VEGF
was found to be responsible for increased permeability of
RSV-infected epithelial monolayers in culture [49]. In the
present study, VEGF was detected at elevated levels in
BALF of both adult and weanling mice at 7 d post infec-
tion but was not elevated at 5 d (Figure 12), suggesting
that it may play a role in increasing airway responsiveness
cysLT concentrations in BALF from adult and weanling miceFigure 11
cysLT concentrations in BALF from adult and weanling mice. Elevated levels were detected at 5 d post RSV infection in adults 
and weanlings, although this did not reach significance in post-hoc analysis in weanlings. Upper and lower limits of detection for 
this assay were 8 and 500 pg/ml, respectively.Page 14 of 18
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timepoints. Despite elevated levels of VEGF, and contrary
to the results of Kilani et al. in vitro [49], epithelial perme-
ability as measured by Evans Blue dye extravasation into
BALF was not increased at the time of peak responsiveness
(7 d post infection) in RSV infected mice in vivo. These
results suggest that epithelial barrier function remained
intact in these animals; however the level of permeability
of the epithelium in these mice simply may not have been
great enough to allow extravasation of the large Evans
Blue dye-albumin complex whilst being sufficient to
allow greater access of MCh (~300 × smaller than albu-
min) to the ASM. Alternatively, the ability of the tech-
nique to detect small increases in epithelial permeability
may have been limited by binding of Evans Blue dye to
airway tissues [50].
Surfactant acts as part of the airway mucosal barrier and
may be involved in the epithelial-specific response to
MCh challenge observed in the present study. Multiple
layers of phospholipid bind directly to the surface of the
bronchial epithelium (reviewed in [51] and contribute to
epithelial barrier function by masking bronchial irritant
receptors that respond to MCh challenge [52,53]. Disrup-
tion of surfactant function by RSV infection (as demon-
strated in mice by [54] and unmasking of irritant receptors
may be sufficient to enhance the level of responsiveness to
aerosolised MCh, although we have not performed any
studies to directly test this hypothesis. Alterations in
responsiveness induced by surfactant dysfunction in RSV
infection would only be detected by MCh delivery directly
to the epithelial surface and would not require increased
epithelial permeability. Bypassing the epithelial layer by
iv administration of MCh and the loss of the surfactant
layer in vitro would not reveal disruption of surfactant
function, and are supported by the results of the present
study.
Role of cytokines and mediators in AHR
Airway and parenchymal hyperresponsiveness were disso-
ciated from inflammatory changes in the low dose model
of RSV infection used in the present study. The level of
hyperresponsiveness seen in these mice far exceeded that
which would be expected for the measured levels of
inflammation. The dissociation between inflammatory
and physiological changes is further emphasised by the
similarity of physiological responses between adult and
weanling mice despite their differing inflammatory pro-
files. In the absence of a significant population of inflam-
matory cells, the innate immune response and products of
resident cells become potential candidates for induction
of hyperresponsiveness. The potential roles of leukot-
rienes and prostaglandins in the hyperresponsiveness
seen in RSV-infected mice in the present study were inves-
tigated due to their ability to influence ASM contraction.
Cysteinyl leukotrienes have profound effects on airway
function; they are potent activators of ASM contraction
[55], they act on the vasculature to produce vasodilation
and increase vascular permeability [56] and stimulate
mucus secretion and interfere with mucociliary clearance
[57]. The role of PGE2 in regulating airway function is
more complex, due in part to the existence of four separate
cell surface receptors with unique signal transduction
mechanisms [58]. PGE2 is potently bronchoprotective in
vitro (reviewed in [59], but has been shown to induce
bronchoconstriction as well as bronchoprotection in
humans [60,61] and animal models [62,63]. Although
VEGF levels in BALF from adult and weanling miceFigure 12
VEGF levels in BALF from adult and weanling mice. Elevated levels were detected at 7 d post RSV infection.Page 15 of 18
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been fully defined, mRNA expression of all four types has
been detected in the mouse lung [64,65]. Airway epithe-
lial cells, mast cells and alveolar macrophages are local
sources of cysLT and PGE2, both of which have been
shown to be elevated in the airways of children with bron-
chiolitis [66-68].
Cysteinyl leukotrienes were significantly elevated in both
adult and weanling mice infected with RSV prior to influx
of inflammatory cells at 7 d post infection (Figure 11),
suggesting that epithelial cells were the main source. cysLT
expression was detected earlier than PGE2, peaking at 5 d
post infection in adult mice, and only elevated at 5 d in
weanling mice. Although consistently detectable at 5 d
post RSV in both age groups, cysLT levels varied markedly
between animals. PGE2 was detected at significantly ele-
vated levels in BALF from both adult and weanling mice
at 7 d post infection (Figure 10). The similarity between
adult and weanling PGE2 levels despite the dramatically
different infiltrating cell populations at these two ages
again suggests that epithelial cells were the predominant
source. The extreme sensitivity of both adult and weanling
mice to MCh challenge at the peak of PGE2 production
indicates that the bronchoprotective effect of PGE2 at
these concentrations was not sufficient to inhibit airway
responsiveness.
Coyle et al (JCI 1995) demonstrated that the cationic pro-
teins major basic protein and poly-L-lysine increased
immunoreactive kinins and kallikrein-like activity in vivo
and that this mechanism explained the epithelial-depend-
ant increase in MCh responsiveness. We did not have the
opportunity of studying kinins and so can not comment
on whether similar mechanisms may underlie the epithe-
lial-dependent MCh responsiveness we report following
RSV infection.
Age-dependent effects of RSV infection
Despite equal levels of viral replication in adult and wean-
ling mice, significant differences were observed in the
inflammatory response to RSV. The lack of a significant
cell-mediated immune response in weanling mice sug-
gests that differences in the level of the host innate
immune response to RSV may have been responsible for
the disparity in responsiveness between the two age
groups. The lack of MCP-1 expression detected in BALF
from weanling mice may be indicative of a general paucity
of chemoattractant chemokine production in this age
group. The similarity of physiological responses despite
marked differences in cell mediated immunity between
adult and weanling mice highlights the issues associated
with characterising infection models solely in adult ani-
mals with mature immune systems. These data also argue
for the need for a systematic study of the effect of age on
the effects of viral infections in mouse models.
Summary
Infection of adult and weanling mice with 1 × 105 pfu RSV
induced significant alterations in airway and parenchymal
responsiveness to bronchoconstrictor challenge.
Increased responsiveness occurred in the absence of base-
line changes in airway or parenchymal physiology, and in
conjunction with mild inflammatory changes. Route-spe-
cificity of MCh responsiveness and elevated levels of epi-
thelial-derived mediators indicated that epithelial
mechanisms were the main determinants of altered respi-
ratory function.
The model described in the present study may provide a
useful basis for assessment of the specific physiological
effects of mild RSV lower respiratory tract infection on air-
way function. Although great caution should always be
maintained when translating data from mouse models to
humans, VEGF-mediated increases in epithelial permea-
bility may be a mechanism by which RSV mediates air-
ways hyperresponsiveness in the human disease.
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